FDA
Signed April 18: Trump EO Cuts Psychedelic Reviews to 1-2 Months
FDA will issue Commissioner's National Priority Vouchers to psychedelic Breakthrough Therapy drugs, including Compass Pathways' COMP360 psilocybin program…
Latest — Page 16
FDA
Gilead Cuts Arcus Ties After Domvanalimab Phase 3 Failure
Domvanalimab has failed its pivotal phase 3 trial in untreated metastatic non-small cell lung cancer, and Gilead Sciences is stepping back from its…
Legal
CBP Opens $166B IEEPA Refund Portal, Full Payout Still Uncertain
CBP opened the CAPE portal today, placing 330,000-plus importers in line for a share of $166 billion in IEEPA duties, two months after the Supreme Court…
AI
California Chatbot Law Live; Oregon, Washington Queue 2027
California SB 243 in force Jan 2026; Oregon SB 1546 and Washington HB 2225 follow Jan 2027. Three overlapping chatbot regimes — what operators owe each state.
ai
AI
Texas TRAIGA at 110 Days — What the 60-Day Cure Period Actually Buys You
Texas TRAIGA (HB 149) took effect Jan 1, 2026. A 60-day cure period gives operators breathing room, but AG-exclusive enforcement means one target, one outcome.
ai
AI
Mobley v. Workday Expands to HiredScore in AI-Hiring Suit
Mobley v. Workday won collective certification in May 2025 and expanded to HiredScore AI users in July. Every HR-tech vendor using ML scoring is now a potential defendant.
ai
AI
FTC Drops Rytr AI Order; Operation AI Comply Retreats
The FTC reopened and vacated the Rytr consent order Dec 22, 2025, citing Trump's AI Action Plan. Cleo AI ($17M), DoNotPay, and Evolv orders are still live.
ai
AI
Colorado AI Act Live in 10 Weeks; Deployers Owe by June 30
The Colorado AI Act (SB 24-205) takes effect June 30, 2026 after a 2025 delay. Impact assessments, consumer notices, and AG-only enforcement — what deployers need ready.
ai
AI
SEC Charged Nate Founder $42M for AI-Washing
SEC charged Nate founder Albert Saniger with $42M AI-washing fraud. A year later, AI-washing is bipartisan SEC priority — and a line item on every founder's pitch deck.
ai
Legal
Opened: CBP's $127B Tariff Refund Portal; Walmart Owed $10.2B
Following the Supreme Court's February ruling that invalidated tariffs collected under the International Emergency Economic Powers Act, U.S. Customs and…
Legal
Zaglin Drops New Trial Motion, 8-Year FCPA Sentence Stands
Carl Zaglin, convicted of FCPA violations in the Southern District of Florida, has withdrawn his Second Motion for a New Trial — quietly collapsing a bid…
FDA
Trump EO Cuts Psychedelic Reviews, Compass Jumps 25%
Trump signed an executive order Saturday directing FDA to issue Commissioner's National Priority Vouchers (CNPVs) to psychedelic drugs with breakthrough…
Deals
Kelonia Sale Hands Venrock a 45-Fold Return on $20M
Venrock put $20 million into Kelonia Therapeutics.
FDA
Trump Backs FDA Push to Fast-Track Psychedelic Treatments
Trump has vowed to push FDA to expedite psychedelic drug development.
FDA
Wins Third Phase 3 in COPD: AstraZeneca's Tozorakimab Eyes $5B Peak
Tozorakimab now has three phase 3 COPD wins in 2026.
